Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Virology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VIROL.2006.02.011PMID 16740288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.

  2005cited by this paper
• Antibody vs. HIV in a clash of evolutionary titans.

  2005cited by this paper
• Progress toward an HIV vaccine.

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

  2005cited by this paper
• Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites

  2005cited by this paper
• Identifying epitopes of HIV-1 that induce protective antibodies

  2004cited by this paper
• The antiviral activity of antibodies in vitro and in vivo

  2004cited by this paper
• Recruitment of different subsets of antigen‐presenting cells selectively modulates DNA vaccine‐elicited CD4+ and CD8+ T lymphocyte responses

  2004cited by this paper
• Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays

  2004cited by this paper
• New hope for AIDS vaccine.

  2003cited by this paper
• Rapid evolution of the neutralizing antibody response to HIV type 1 infection

  2003influential reference
• Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition

  2003cited by this paper
• Gp120-Alum Boosting of a Gag-Pol-Env DNA/MVA AIDS Vaccine: Poorer Control of a Pathogenic Viral Challenge

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003influential reference
• Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand.

  2003cited by this paper
• A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.

  2002cited by this paper
• Vaccines: New hope for an aids vaccine

  2002cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

  2002cited by this paper
• Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239

  2002cited by this paper
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

  2002cited by this paper
• Protection of Rhesus Macaques against Lethal Plasmodium knowlesi Malaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization Regimen

  2002cited by this paper
• Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

  2002cited by this paper
• Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

  2002cited by this paper
• Mouse and human dendritic cell subtypes

  2002cited by this paper
• Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF1

  2002cited by this paper
• Membrane-Fusing Capacity of the Human Immunodeficiency Virus Envelope Proteins Determines the Efficiency of CD4+ T-Cell Depletion in Macaques Infected by a Simian-Human Immunodeficiency Virus

  2001cited by this paper
• Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype) * *

  2001cited by this paper
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

  2001cited by this paper
• Origin and differentiation of dendritic cells.

  2001cited by this paper
• Polyethylene Glycol-Modified GM-CSF Expands CD11bhighCD11chigh But Not CD11blowCD11chigh Murine Dendritic Cells In Vivo: A Comparative Analysis with Flt3 Ligand

  2000cited by this paper
• Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function

  2000cited by this paper
• Sensitive and Robust One-Tube Real-Time Reverse Transcriptase-Polymerase Chain Reaction to Quantify SIV RNA Load: Comparison of One- versus Two-Enzyme Systems

  2000cited by this paper
• Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production

  2000cited by this paper
• Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles1

  2000cited by this paper
• Follicular Homing T Helper (Th) Cells and the Th1/Th2 Paradigm

  2000cited by this paper
• Immunization with Recombinant Canarypox Vectors Expressing Membrane-Anchored Glycoprotein 120 Followed by Glycoprotein 160 Boosting Fails to Generate Antibodies That Neutralize R5 Primary Isolates of Human Immunodeficiency Virus Type 1

  2000cited by this paper
• Co‐immunization with DNA vaccines expressing granulocyte–macrophage colony‐stimulating factor and mycobacterial secreted proteins enhances T‐cell immunity, but not protective efficacy against Mycobacterium tuberculosis

  1999cited by this paper
• Optimal Induction of Hepatitis C Virus Envelope-Specific Immunity by Bicistronic Plasmid DNA Inoculation with the Granulocyte-Macrophage Colony-Stimulating Factor Gene

  1998cited by this paper
• Enhancement of protective humoral (Th2) and cell‐mediated (Th1) immune responses against herpes simplex virus‐2 through co‐delivery of granulocyte‐macrophage colony‐stimulating factor expression cassettes

  1998cited by this paper
• A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.

  1998cited by this paper
• Neutralizing antibodies are positively associated with CD4+ T‐cell counts and T‐cell function in long‐term AIDS‐free infection

  1998cited by this paper
• Characterization of Simian-Human Immunodeficiency Virus Envelope Glycoprotein Epitopes Recognized by Neutralizing Antibodies from Infected Monkeys

  1998cited by this paper
• Neutralizing Antibodies in Sera from Macaques Infected with Chimeric Simian-Human Immunodeficiency Virus Containing the Envelope Glycoproteins of either a Laboratory-Adapted Variant or a Primary Isolate of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity

  1998cited by this paper
• The antigenic structure of the HIV gp120 envelope glycoprotein

  1998cited by this paper
• A vaccine for HIV type 1: the antibody perspective.

  1997cited by this paper
• Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.

  1997cited by this paper
• Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals

  1997cited by this paper
• Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

  1997cited by this paper
• Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys

  1997influential reference
• Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.

  1997cited by this paper
• Cytokines and costimulatory molecules as genetic adjuvants

  1997cited by this paper
• A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys

  1996cited by this paper
• An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys

  1996cited by this paper
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

  1995cited by this paper
• Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

  1995cited by this paper
• In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.

  1993cited by this paper
• Current protocols in immunology

  1991cited by this paper
• Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay

  1988cited by this paper

• Advances in Infectious Disease Vaccine Adjuvants

  2022cites this paper
• Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models

  2017cites this paper
• Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins

  2017cites this paper
• Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

  2016cites this paper
• High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques

  2016cites this paper
• Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs

  2015influential citation
• Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses

  2015cites this paper
• Recent Advances and Current Status of GM-CSF as an Adjuvant in DNA Vaccines for Viral Diseases

  2015cites this paper
• Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine

  2015cites this paper
• An HIV-1 Mini Vaccine Induced Long-lived Cellular and Humoral Immune Responses

  2015cites this paper
• Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR

  2014cites this paper
• DNA/MVA Vaccines for HIV/AIDS

  2014cites this paper
• HIV DNA Vaccine: Stepwise Improvements Make a Difference

  2014cites this paper
• Modulation of HIV-1 immunity by adjuvants

  2014cites this paper
• Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency

  2014cites this paper
• Characterization of a Novel Mycobacterium Tuberculosis-Simian Immunodeficiency Virus Vaccine to Prevent Oral Pediatric HIV Transmission

  2014cites this paper
• Desenvolvimento de estratégias para aumento da imunogenicidade da vacina de DNA HIVBr18 baseadas na fusão com a glicoproteína D do herpes vírus humano tipo 1 e na coadministração de citocinas

  2014cites this paper
• Dynamics of Cytokine/Chemokine Responses in Intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus Infection

  2013cites this paper
• Synthetic DNA vaccine strategies against persistent viral infections

  2013cites this paper
• A brief history of the global effort to develop a preventive HIV vaccine.

  2013cites this paper
• Technologies for enhanced efficacy of DNA vaccines

  2012cites this paper
• Membrane-bound immunomodulators as adjuvants in a cell culture-based avian influenza vaccine

  2012cites this paper
• A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses*

  2011cites this paper
• Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

  2011cites this paper
• Effects of immunization against a DNA vaccine encoding somatostatin gene (pGM-CSF/SS) by attenuated Salmonella typhimurium on growth, reproduction and lactation in female mice.

  2011cites this paper
• ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.

  2011cites this paper
• Clinical applications of DNA vaccines: current progress.

  2011cites this paper
• Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

  2011cites this paper
• HIV-1 specific humoral immune responses in healthy volunteers after HIV DNA prime-HIV MVA boost immunization

  2010cites this paper
• GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates

  2010cites this paper
• Vaccine Adjuvants

  2010cites this paper
• Preexisting Vaccinia Virus Immunity Decreases SIV-Specific Cellular Immunity but Does Not Diminish Humoral Immunity and Efficacy of a DNA/MVA Vaccine

  2010cites this paper
• HIV-1 specific humoral immune responses in healthy volunteers after DNA prime-MVA boost immunization

  2010cites this paper
• Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs

  2010cites this paper
• Env-Expressing Autologous T Lymphocytes Induce Neutralizing Antibody and Afford Marked Protection against Feline Immunodeficiency Virus

  2010cites this paper
• and Efficacy of a DNA/MVA Vaccine but Does Not Diminish Humoral Immunity Decreases SIV-Specific Cellular Immunity Preexisting Vaccinia Virus Immunity

  2010cites this paper
• Adjuvant activity of cytokines.

  2010cites this paper
• Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.

  2009cites this paper
• HIV-1 immune responses induced by natural infection or immunisation

  2009cites this paper
• Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.

  2009cites this paper
• Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

  2009cites this paper
• Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.

  2009cites this paper
• Susceptibility to Simian Immunodeficiency Virus Ex Vivo Predicts Outcome of a Prime-Boost Vaccine After SIVmac239 Challenge

  2009cites this paper
• Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques

  2008cites this paper
• Better Protective Effects in Rhesus Macaques by Combining Systemic and Mucosal Application of a Dual Component Vector Vaccine After Rectal SHIV89.6P Challenge Compared to Systemic Vaccination Alone

  2008cites this paper
• Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.

  2007cites this paper
• Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.

  2007cites this paper
• Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination

  2007cites this paper
• GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.

  2007cites this paper
• A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate.

  2007cites this paper
• Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses

  2007cites this paper
• Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management

  2007cites this paper
• Improving vaccines by incorporating immunological coadjuvants

  2007cites this paper
• Prime-boost immunization strategies against HIV-1

  2007cites this paper
• Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

  2007cites this paper
• Vaccine delivery methods using viral vectors.

  2007cites this paper